- Deborah S Jacobs, MD
Deborah S Jacobs, MD
- Associate Professor of Ophthalmology, Part-Time
- Harvard Medical School
Conjunctivitis is a common patient complaint. It is the most likely diagnosis in a patient with a red eye and discharge. (See "Evaluation of the red eye".)
Acute conjunctivitis is usually a benign, self-limited condition or one that is easily treated. When making a diagnosis of acute conjunctivitis, one needs to make certain that sight-threatening and pathologic processes have been ruled out. In contrast to acute conjunctivitis, these entities, such as acute angle closure glaucoma, iritis, and infectious keratitis, must be managed by ophthalmologists and will not be discussed here.
Conjunctivitis literally means "inflammation of the conjunctiva." The conjunctiva is the mucous membrane that lines the inside surface of the lids and covers the surface of the globe up to the limbus (the junction of the sclera and the cornea). The portion covering the globe is the "bulbar conjunctiva," and the portion lining the lids is the "tarsal conjunctiva."
The conjunctiva is comprised of an epithelium and a substantia propria. The epithelium is a non-keratinized squamous epithelium that also contains goblet cells. The substantia propria is highly vascularized and is the site of considerable immunologic activity.
The conjunctiva is generally transparent. When it is inflamed, as in conjunctivitis, it looks pink or red at a distance. Up close the examiner can discern fine blood vessels, termed "injection," in contrast to extravasated blood, which is seen in subconjunctival hemorrhage. Degenerative, inflammatory, and infiltrative processes can cause the conjunctiva to become opacified, taking on a white, yellow, or fleshy appearance. All conjunctivitis is characterized by a red eye, but not all red eyes are conjunctivitis. (See "Evaluation of the red eye".)To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information on subscription options, click below on the option that best describes you:
- Weiss A, Brinser JH, Nazar-Stewart V. Acute conjunctivitis in childhood. J Pediatr 1993; 122:10.
- Fitch CP, Rapoza PA, Owens S, et al. Epidemiology and diagnosis of acute conjunctivitis at an inner-city hospital. Ophthalmology 1989; 96:1215.
- Gigliotti F, Williams WT, Hayden FG, et al. Etiology of acute conjunctivitis in children. J Pediatr 1981; 98:531.
- Friedlaender MH. A review of the causes and treatment of bacterial and allergic conjunctivitis. Clin Ther 1995; 17:800.
- Martin M, Turco JH, Zegans ME, et al. An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med 2003; 348:1112.
- Crum NF, Barrozo CP, Chapman FA, et al. An outbreak of conjunctivitis due to a novel unencapsulated Streptococcus pneumoniae among military trainees. Clin Infect Dis 2004; 39:1148.
- Rietveld RP, ter Riet G, Bindels PJ, et al. Predicting bacterial cause in infectious conjunctivitis: cohort study on informativeness of combinations of signs and symptoms. BMJ 2004; 329:206.
- Ullman S, Roussel TJ, Culbertson WW, et al. Neisseria gonorrhoeae keratoconjunctivitis. Ophthalmology 1987; 94:525.
- Wan WL, Farkas GC, May WN, Robin JB. The clinical characteristics and course of adult gonococcal conjunctivitis. Am J Ophthalmol 1986; 102:575.
- Roba LA, Kowalski RP, Gordon AT, et al. Adenoviral ocular isolates demonstrate serotype-dependent differences in in vitro infectivity titers and clinical course. Cornea 1995; 14:388.
- Azar MJ, Dhaliwal DK, Bower KS, et al. Possible consequences of shaking hands with your patients with epidemic keratoconjunctivitis. Am J Ophthalmol 1996; 121:711.
- Jernigan JA, Lowry BS, Hayden FG, et al. Adenovirus type 8 epidemic keratoconjunctivitis in an eye clinic: risk factors and control. J Infect Dis 1993; 167:1307.
- Sambursky R, Tauber S, Schirra F, et al. The RPS adeno detector for diagnosing adenoviral conjunctivitis. Ophthalmology 2006; 113:1758.
- Udeh BL, Schneider JE, Ohsfeldt RL. Cost effectiveness of a point-of-care test for adenoviral conjunctivitis. Am J Med Sci 2008; 336:254.
- Cheng KH, Leung SL, Hoekman HW, et al. Incidence of contact-lens-associated microbial keratitis and its related morbidity. Lancet 1999; 354:181.
- Tabbara KF, El-Sheikh HF, Aabed B. Extended wear contact lens related bacterial keratitis. Br J Ophthalmol 2000; 84:327.
- Rose PW, Harnden A, Brueggemann AB, et al. Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial. Lancet 2005; 366:37.
- Sheikh A, Hurwitz B, van Schayck CP, et al. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database Syst Rev 2012; :CD001211.
- Wilkins MR, Khan S, Bunce C, et al. A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis. Br J Ophthalmol 2011; 95:1299.
- Ophthalmic azithromycin (AzaSite). Med Lett Drugs Ther 2008; 50:11.
- Friedlaender MH. The current and future therapy of allergic conjunctivitis. Curr Opin Ophthalmol 1998; 9:54.
- Ciprandi G, Buscaglia S, Cerqueti PM, Canonica GW. Drug treatment of allergic conjunctivitis. A review of the evidence. Drugs 1992; 43:154.
- ETIOLOGY AND CLINICAL MANIFESTATIONS
- Bacterial conjunctivitis
- - Hyperacute bacterial conjunctivitis
- - Chlamydial infections
- Adult inclusion conjunctivitis
- Viral conjunctivitis
- - Epidemic keratoconjunctivitis
- Allergic conjunctivitis
- Noninfectious, nonallergic conjunctivitis
- General approach
- Distinguishing bacterial conjunctivitis
- Pitfalls in diagnosis
- - Contact lens wearers
- Red flags
- General considerations
- Specific therapy
- - Bacterial
- - Viral
- - Adult inclusion conjunctivitis
- - Allergic
- - Noninfectious nonallergic
- Persistent symptoms
- RETURNING TO WORK, SCHOOL, OR SPORTS
- INFORMATION FOR PATIENTS
- SUMMARY AND RECOMMENDATIONS